Natural history of ovarian cancer

ecancermedicalscience

Volumn 8, Issue , 2014, Pages

  Varqa, Arturo Novoa ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

Natural history; Ovarian cancer

Indexed keywords

BRCA2 PROTEIN;

CANCER GROWTH; CANCER MORTALITY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CAUSE OF DEATH; CHROMOSOME 17; FAMILIAL CANCER; GERMLINE MUTATION; HISTOPATHOLOGY; HISTORY; HUMAN; MOLECULAR DIAGNOSIS; OVARY CANCER; REVIEW;

EID: 84907664938     PISSN: None     EISSN: 17546605     Source Type: Journal    
DOI: 10.3332/ecancer.2014.465     Document Type: Review

References (28)

1. Ferlay J et al (2008) GLOBOCAN 2008, Cancer incidence and mortality worldwide http://globocan.iarc.fr. Date accessed: 23 January 2013
2. Hannibal CG et al (2008) Survival of ovarian cancer patients in Denmark: excess mortality risk analysis of five year relative survival 1978-2002 Acta Obstet Gynecol Scand 87(12) 1353-60 DOI: 10.1080/00016340802483000 PMID: 18951210
3. Sant M et al (2003) EUROCARE-3: survival of cancer patients diagnosed 1990-94 - results and commentary Ann Oncol 2003 14 (Suppl 5) v61-v118 DOI: 10.1093/annonc/mdg754
4. Jemal A et al (2008) Cancer statistics 2008 CA Cancer Jr Clin 58 71-96 DOI: 10.3322/CA.2007.0010
5. Chan JK et al (2006) Patterns a progress in ovarian cancer over 14 years Obstet Gynecol 108 (3 Pt 1) 521-528 DOI: 10.1097/01. AOG.0000231680.58221.a7 PMID: 16946210
6. Gallardo-Rincón et al (2011) Tercer consenso Nacional de Cáncer de ovario 2011 Rev Invest Clin 63(6) 665-702 PMID: 23650680
7. Scully RE, Young RH and Clement PB (1998) Tumors of the ovary, maldeveloped gonads, fallopian tube, and broad ligament Atlas Tumor Pathol Vol Fascicle 23 3rd series Washington DC Armed Forces Institute of Pathology 1-168
8. American Joint Committee on Cancer (2002) AJCC Cancer Staging Manual 6th edn, ed FL Greene, DL Page, ID Fleming, AG Fritz, CM Balch, DG Haller and M Morrow (New York: Springer) pp 275-84 (Ovary)
9. American Cáncer Society (2008) Cancer Facts and Figures 2008 (Atlanta, GA: Am Cancer Soc)
10. Poveda A (2006) Ovarian cancer, national consensus Gaceta Mexicana de Oncología 5(3) suppl. 1-2
11. Geomini Peggy et al (2009) The accuracy of risks scores in prediciting ovarian malignancy, a sistemic review Obst Gynecol 113(2) 384-394 DOI: 10.1097/AOG.0b013e318195ad17
12. Amstrong D et al (2006) Intraperitoneal cisplatin and paclitaxel in ovarian cáncer N Engl J Med 354 34-43 DOI: 10.1056/NEJ-Moa052985
13. Engel J et al (2002) Moderate progress for ovarian cancer in the last 20 years; prolongation of survival, but no improvement in the cure rate EurJ Cancer 38 2435-45 DOI: 10.1016/S0959-8049(02)00495-1 PMID: 12460769
14. Herráez Á (2012) Biología Molecular e Ingeniería Genética 2nd ed (España: Elsevier) pp 449-479chapter26(BasesMolecularesdelCáncer) del Cáncer)
15. Riman T et al (2002) Risk factors for invasive eepithelial ovarian cáncer: result from a Swedish case-control study Am J Epidemiol 156(4) 363-73 DOI: 10.1093/aje/kwf048 PMID: 12181107
16. M. , Beral V. and Smith P. (1989) Risk factors for ovarian cancer: a case control study Br J Cancer 60 592-8 DOI:10.1038/bjc.1989.320 PMID: 2679848 PMCID: 2247100
17. Brinton Louise A et al (2010) Cancer risk among infertile women with androgen excess or menstrual disorders including polycystic ovary syndrome Fertility and Sterility 94 1787-1792 DOI: 10.1016/j.fertnstert.2009.10.012
18. Herráez Á (2012) Biología Molecular e Ingeniería Genética 2nd ed (España: Elsevier) pp 449-479 chapter 26 (Bases Moleculares del Cáncer)
19. Riman T et al (2002) Risk factors for invasive eepithelial ovarian cáncer: result from a Swedish case-control study Am J Epidemiol 156(4) 363-73 DOI: 10.1093/aje/kwf048 PMID: 12181107
20. Booth M, Beral V and Smith P (1989) Risk factors for ovarian cancer: a case control study Br J Cancer 60 592-8 DOI: 10.1038/ bjc.1989.320 PMID: 2679848 PMCID: 2247100
21. Brinton Louise A et al (2010) Cancer risk among infertile women with androgen excess or menstrual disorders including polycystic ovary syndrome Fertility and Sterility 94 1787-1792 DOI: 10.1016/j.fertnstert.2009.10.012
22. Risch H, Marett L and Howe G (1994) Parity, contraception, infertility, and risk of epithelial ovarian cancer Am J Epidemiol 140(7) 585-97 PMID: 7942759
23. Yoshida Hiroyuki et al (2005) Steroid receptor coactivator-3, a homolog of Taiman that controls cell migration in the Drosophila ovary, regulates migration of human ovarian cancer cells Mol Cell Endocrinol 245 77-85 PMID: 16298470
24. Stammer Karen et al (2008) Selenium-binding protein, expression in ovaries and ovarian tumors in the laying hen and spontaneous model of human ovarian cancer Gynecol Oncol 109 115-121 DOI: 10.1016/j.ygyno.2007.12.030 PMID: 18272210 PMCID: 2387249
25. Allahbadia Gautam N and Merchant Rubina (2011) Polycystic ovary syndrome and impact on health Middle East Fertility Society Journal 1619-37 DOI: 10.1016/j.mefs.2010.10.002
26. Diaz Gomez Ml, Tamayo Daniel and Castro Jose A Nitrosodimethylamine metabolism in rat ovaries. Interactions of its metabolites with nucleic acids and proteins Cancer Lett 41(3) 257-263 PMID: 3409204
27. Herrera Gómez Á and Gallardo Rincón D (2000) Manual de oncología (México: MacGraw-Hill Interamericana) pp 410-26 chapter 54 (Cáncer Epitelial del Ovario, InCan)
28. Farghaly Samir A (2013) The role of oral contraceptives pills(OCPs) in chemoprevention fo epithelial ovarian cáncer in women with mutant BRCA1 and BRCA2 genes J Cancer Sci Ther 5(8) 1000-124